Tapewire

NYSE · USD

XYL

Xylem Inc.

Export transactions ↓
Tapewire entity
430
SEC CIK
0001524472
Parsed reports
533

Last 12 months

Inside the activity.

1 purchase rows · 2 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202611
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 27, 2023 Filed Feb 28, 2023 19:35 UTC Tax withholdingCommon Stock 287 $102.55 $29,431.85
Disclosure

SEC source: 0001562180-23-002021 · primarydocument.xml · nonDerivative · entry 3

Toussaint Claudia S · CIK 0001421560 · SVP, CPSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,183

F3 · shares: Reflects units withheld to pay the tax liability incident to the vesting of restricted stock units granted on February 27, 2020 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).

F4 · balance_after: Includes 35,482 shares held by the Claudia S. Toussaint Revocable Trust.

Read SEC document
February 27, 2023 Filed Feb 28, 2023 19:35 UTC Tax withholdingCommon Stock 1,415 $102.55 $145,108.25
Disclosure

SEC source: 0001562180-23-002021 · primarydocument.xml · nonDerivative · entry 2

Toussaint Claudia S · CIK 0001421560 · SVP, CPSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,470

F2 · shares: Reflects units withheld to pay the tax liability incident to the vesting of performance-based restricted stock units granted on February 27, 2020 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).

Read SEC document
February 27, 2023 Filed Feb 28, 2023 19:35 UTC GrantCommon Stock 4,546 $0.00 $0.00
Disclosure

SEC source: 0001562180-23-002021 · primarydocument.xml · nonDerivative · entry 1

Toussaint Claudia S · CIK 0001421560 · SVP, CPSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,885

F1 · shares: Reflects shares of common stock earned upon vesting of performance-based restricted stock units granted February 27, 2020 upon achievement of performance criteria related to Total Shareholder Return.

Read SEC document
February 27, 2023 Filed Feb 28, 2023 19:30 UTC
Decker PatrickDirector · President & CEO
Tax withholdingCommon Stock 3,199 $102.55 $328,057.45
Disclosure

SEC source: 0001562180-23-002014 · primarydocument.xml · nonDerivative · entry 3

Decker Patrick · CIK 0001403434 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 276,393

F3 · shares: Reflects units withheld to pay the tax liability incident to the vesting of restricted stock units granted on February 27, 2020 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).

Read SEC document
February 27, 2023 Filed Feb 28, 2023 19:30 UTC
Decker PatrickDirector · President & CEO
Tax withholdingCommon Stock 13,902 $102.55 $1,425,650.10
Disclosure

SEC source: 0001562180-23-002014 · primarydocument.xml · nonDerivative · entry 2

Decker Patrick · CIK 0001403434 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 279,592

F2 · shares: Reflects units withheld to pay the tax liability incident to the vesting of performance-based restricted stock units granted on February 27, 2020 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).

Read SEC document
February 27, 2023 Filed Feb 28, 2023 19:30 UTC
Decker PatrickDirector · President & CEO
GrantCommon Stock 30,313 $0.00 $0.00
Disclosure

SEC source: 0001562180-23-002014 · primarydocument.xml · nonDerivative · entry 1

Decker Patrick · CIK 0001403434 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 293,494

F1 · shares: Reflects shares of common stock earned upon vesting of performance-based restricted stock units granted February 27, 2020 upon achievement of performance criteria related to Total Shareholder Return.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 00:31 UTC
Yarkadas HayatiSVP & President, EU, WI & GLS
Tax withholdingCommon Stock 64 $102.55 $6,563.20
Disclosure

SEC source: 0001562180-23-002020 · primarydocument.xml · nonDerivative · entry 3

Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,875

F3 · shares: Reflects units withheld to pay the tax liability incident to the vesting of restricted stock units granted on May 7, 2020 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).

Read SEC document
February 27, 2023 Filed Mar 1, 2023 00:31 UTC
Yarkadas HayatiSVP & President, EU, WI & GLS
Tax withholdingCommon Stock 306 $102.55 $31,380.30
Disclosure

SEC source: 0001562180-23-002020 · primarydocument.xml · nonDerivative · entry 2

Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,939

F2 · shares: Reflects units withheld to pay the tax liability incident to the vesting of performance-based restricted stock units granted on May 7, 2020 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).

Read SEC document
February 27, 2023 Filed Mar 1, 2023 00:31 UTC
Yarkadas HayatiSVP & President, EU, WI & GLS
GrantCommon Stock 5,772 $0.00 $0.00
Disclosure

SEC source: 0001562180-23-002020 · primarydocument.xml · nonDerivative · entry 1

Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,245

F1 · shares: Reflects shares of common stock earned upon vesting of performance-based restricted stock units granted May 7, 2020 upon achievement of performance criteria related to Total Shareholder Return.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 00:30 UTC
McShane Geri-MichelleVP, Controller & CAO
Tax withholdingCommon Stock 78 $102.55 $7,998.90
Disclosure

SEC source: 0001562180-23-002017 · primarydocument.xml · nonDerivative · entry 3

McShane Geri-Michelle · CIK 0001769064 · VP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,387

F4 · shares: Reflects units withheld to pay the tax liability incident to the vesting of restricted stock units granted on February 27, 2020 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).

Read SEC document
February 27, 2023 Filed Mar 1, 2023 00:30 UTC
McShane Geri-MichelleVP, Controller & CAO
Tax withholdingCommon Stock 420 $102.55 $43,071.00
Disclosure

SEC source: 0001562180-23-002017 · primarydocument.xml · nonDerivative · entry 2

McShane Geri-Michelle · CIK 0001769064 · VP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,465

F3 · shares: Reflects units withheld to pay the tax liability incident to the vesting of performance-based restricted stock units granted on February 27, 2020 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).

Read SEC document
February 27, 2023 Filed Mar 1, 2023 00:30 UTC
McShane Geri-MichelleVP, Controller & CAO
GrantCommon Stock 1,011 $0.00 $0.00
Disclosure

SEC source: 0001562180-23-002017 · primarydocument.xml · nonDerivative · entry 1

McShane Geri-Michelle · CIK 0001769064 · VP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,885

F1 · shares: Reflects shares of common stock earned upon vesting of performance-based restricted stock units granted February 27, 2020 upon achievement of performance criteria related to Total Shareholder Return.

F2 · balance_after: Includes additional shares due to dividend reinvestment.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 00:30 UTC
McGann Michael J.SVP & President Americas & MCS
Tax withholdingCommon Stock 67 $102.55 $6,870.85
Disclosure

SEC source: 0001562180-23-002016 · primarydocument.xml · nonDerivative · entry 3

McGann Michael J. · CIK 0001962070 · SVP & President Americas & MCS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,048

F3 · shares: Reflects units withheld to pay the tax liability incident to the vesting of restricted stock units granted on February 27, 2020 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).

Read SEC document
February 27, 2023 Filed Mar 1, 2023 00:30 UTC
McGann Michael J.SVP & President Americas & MCS
Tax withholdingCommon Stock 386 $102.55 $39,584.30
Disclosure

SEC source: 0001562180-23-002016 · primarydocument.xml · nonDerivative · entry 2

McGann Michael J. · CIK 0001962070 · SVP & President Americas & MCS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,115

F2 · shares: Reflects units withheld to pay the tax liability incident to the vesting of performance-based restricted stock units granted on February 27, 2020 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).

Read SEC document
February 27, 2023 Filed Mar 1, 2023 00:30 UTC
McGann Michael J.SVP & President Americas & MCS
GrantCommon Stock 1,136 $0.00 $0.00
Disclosure

SEC source: 0001562180-23-002016 · primarydocument.xml · nonDerivative · entry 1

McGann Michael J. · CIK 0001962070 · SVP & President Americas & MCS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,501

F1 · shares: Reflects shares of common stock earned upon vesting of performance-based restricted stock units granted February 27, 2020 upon achievement of performance criteria related to Total Shareholder Return.

Read SEC document
February 15, 2023 Filed Feb 17, 2023 21:58 UTC
Yarkadas HayatiSenior Vice President
SaleCommon Stock 2,083 $106.94 $222,756.02
Disclosure

SEC source: 0001562180-23-001517 · primarydocument.xml · nonDerivative · entry 1

Yarkadas Hayati · CIK 0001657363 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,473

Read SEC document
November 04, 2022 Filed Nov 8, 2022 16:53 UTC
Pine Matthew FrancisSenior Vice President
SaleCommon Stock 900 $108.45 $97,605.00
Disclosure

SEC source: 0001209191-22-056118 · doc4.xml · nonDerivative · entry 3

Pine Matthew Francis · CIK 0001807057 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,819

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2022.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.39 to $109.3899, inclusive. The reporting person undertakes to provide to Xylem, Inc., any security holder of Xylem, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth in Footnote 5 to this Form 4.

Read SEC document
November 04, 2022 Filed Nov 8, 2022 16:53 UTC
Pine Matthew FrancisSenior Vice President
SaleCommon Stock 3,382 $107.76 $364,444.32
Disclosure

SEC source: 0001209191-22-056118 · doc4.xml · nonDerivative · entry 2

Pine Matthew Francis · CIK 0001807057 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,719

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2022.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.35 to $108.3499, inclusive. The reporting person undertakes to provide to Xylem, Inc., any security holder of Xylem, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth in Footnote 4 to this Form 4.

Read SEC document
November 04, 2022 Filed Nov 8, 2022 16:53 UTC
Pine Matthew FrancisSenior Vice President
SaleCommon Stock 7,588 $106.68 $809,487.84
Disclosure

SEC source: 0001209191-22-056118 · doc4.xml · nonDerivative · entry 1

Pine Matthew Francis · CIK 0001807057 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,101

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.33 to $107.3299, inclusive. The reporting person undertakes to provide to Xylem, Inc., any security holder of Xylem, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth in Footnote 2 to this Form 4.

F3 · balance_after: Includes additional shares due to dividend reinvestment.

Read SEC document
November 04, 2022 Filed Dec 1, 2022 21:54 UTC
Flinton DavidSenior Vice President
Tax withholdingCommon Stock 373 $107.21 $39,989.33
Disclosure

SEC source: 0001209191-22-059208 · doc4.xml · nonDerivative · entry 1

Flinton David · CIK 0001654800 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,233

F1 · shares: Reflects the withholding of common stock to pay the tax liability incident to the vesting of restricted stock units granted on November 4, 2019, under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated as of February 24, 2016).

F2 · balance_after: Includes additional shares due to dividend reinvestment.

Read SEC document
September 06, 2022 Filed Sep 8, 2022 14:43 UTC
Toussaint Claudia SSenior Vice President
SaleCommon Stock 16,825 $91.37 $1,537,264.92
Disclosure

SEC source: 0001209191-22-049130 · doc4.xml · nonDerivative · entry 1

Toussaint Claudia S · CIK 0001421560 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,786

F1 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 16,525 Shares were executed at a range of prices from $90.97 to $91.9699. 300 Shares were executed at a range of prices from $92.07 to $93.0699.The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

F2 · price: Includes additional shares due to dividend reinvestment.

F3 · price: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on August 4, 2022.

Read SEC document
August 10, 2022 Filed Aug 11, 2022 20:27 UTC SaleCommon Stock 5,000 $100.26 $501,287.00
Disclosure

SEC source: 0001209191-22-045423 · doc4.xml · nonDerivative · entry 1

Harker Victoria D · CIK 0001350579 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,099

F1 · price: This price represents the weighted average price per Share of the Issuer. Shares were sold at prices ranging from $100.2571 to $100.2700. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price

Read SEC document
August 04, 2022 Filed Aug 5, 2022 15:34 UTC SaleCommon Stock 600 $96.65 $57,990.00
Disclosure

SEC source: 0001209191-22-044502 · doc4.xml · nonDerivative · entry 1

Beliveau-Dunn Jeanne · CIK 0001714894 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,553

F1 · balance_after: Includes additional shares due to Dividend Reinvestment.

F2 · balance_after: These options were exercised and sold pursuant to the Reporting Person's 10b5-1 Plan.

Read SEC document
June 27, 2022 Filed Jun 29, 2022 20:04 UTC
Yarkadas HayatiSenior Vice President
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 5,898 $0.00 Strike: $63.55 $0.00
Disclosure

SEC source: 0001209191-22-039773 · doc4.xml · derivative · entry 3

Yarkadas Hayati · CIK 0001657363 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,076

Underlying: Common Stock · 5,898 shares

Expires 2030-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The May 7, 2020 option grant vests in one third increments on February 27, 2021, February 27, 2022 and February 27, 2023.

Read SEC document
June 27, 2022 Filed Jun 29, 2022 20:04 UTC
Yarkadas HayatiSenior Vice President
SaleCommon Stock 5,898 $80.06 $472,212.16
Disclosure

SEC source: 0001209191-22-039773 · doc4.xml · nonDerivative · entry 2

Yarkadas Hayati · CIK 0001657363 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,556

F1 · shares: The exercise and sale was made pursuant to a 10b5-1 plan adopted by the reporting person on May 19, 2022.

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). Shares were sold at a range of prices from $80.00 to $80.31. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price

Read SEC document
June 27, 2022 Filed Jun 29, 2022 20:04 UTC
Yarkadas HayatiSenior Vice President
Exercise / conversionCommon Stock 5,898 $63.55 $374,817.90
Disclosure

SEC source: 0001209191-22-039773 · doc4.xml · nonDerivative · entry 1

Yarkadas Hayati · CIK 0001657363 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,454

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The exercise and sale was made pursuant to a 10b5-1 plan adopted by the reporting person on May 19, 2022.

Read SEC document
June 21, 2022 Filed Jun 22, 2022 20:06 UTC
Yarkadas HayatiSenior Vice President
SaleCommon Stock 2,082 $74.18 $154,436.10
Disclosure

SEC source: 0001209191-22-038668 · doc4.xml · nonDerivative · entry 1

Yarkadas Hayati · CIK 0001657363 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,556

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on May 19, 2022.

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 1,600 shares were sold at a range of prices from $73.78 to $74.62. 482 shares were sold at a range of prices from $74.80 to $74.84. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price

Read SEC document
June 14, 2022 Filed Jun 14, 2022 16:14 UTC
Cerwinka FranzSVP and President, Emerging Ma
SaleCommon Stock 925 $75.79 $70,105.84
Disclosure

SEC source: 0001209191-22-036662 · doc4.xml · nonDerivative · entry 1

Cerwinka Franz · CIK 0001813828 · SVP and President, Emerging Ma

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,688

F1 · shares: Reflects the sale of common stock to pay the tax liability incident to the vesting of restricted stock units granted on June 12, 2020 under the Xylem 2011 Omnibus Incentive Plan.

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

F3 · balance_after: Amount shown reflects additional shares acquired via a dividend reinvestment plan or DRIP.

Read SEC document
May 12, 2022 Filed May 16, 2022 19:00 UTC GrantCommon Stock 1,812 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-029346 · doc4.xml · nonDerivative · entry 1

TAMBAKERAS MARKOS I · CIK 0001012990 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,140

F1 · shares: Reflects the award of restricted stock units which are scheduled to vest the day before the 2023 Annual Shareowner Meeting.

Read SEC document
May 12, 2022 Filed May 16, 2022 23:01 UTC GrantCommon Stock 1,812 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-029349 · doc4.xml · nonDerivative · entry 1

Tretikov Lila · CIK 0001620654 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,553

F1 · shares: Reflects the issuance of an RSU award which is scheduled to vest the day before the 2023 Annual Shareowner Meeting

F2 · balance_after: Amount shown reflects additional shares acquired via a dividend reinvestment plan or DRIP.

Read SEC document
May 12, 2022 Filed May 16, 2022 22:58 UTC GrantCommon Stock 1,812 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-029343 · doc4.xml · nonDerivative · entry 1

Peribere Jerome A · CIK 0001484527 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,812

F1 · shares: Reflects the award of restricted stock units, which are scheduled to vest on the business day prior to the Xylem Inc. 2023 annual shareholders' meeting.

Read SEC document
May 12, 2022 Filed May 16, 2022 23:03 UTC
Yadav UdayDirector
GrantCommon Stock 1,812 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-029351 · doc4.xml · nonDerivative · entry 1

Yadav Uday · CIK 0001479938 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,541

F1 · shares: Reflects the issuance of an RSU award which is scheduled to vest the day before the 2023 Annual Shareowner Meeting

Read SEC document
May 12, 2022 Filed May 16, 2022 22:54 UTC GrantCommon Stock 1,812 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-029338 · doc4.xml · nonDerivative · entry 1

Morelli Mark D · CIK 0001411290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,232

F1 · shares: Reflects the award of restricted stock units. The Reporting Person elected to defer the vesting of the RSU Award until Separation from Service.

F2 · balance_after: Includes RSUs which the reporting person elected to defer the vesting of the award until Separation from Service.

Read SEC document
May 12, 2022 Filed May 16, 2022 22:53 UTC GrantCommon Stock 1,812 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-029336 · doc4.xml · nonDerivative · entry 1

Harker Victoria D · CIK 0001350579 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,099

F1 · shares: Reflects the issuance of an RSU award which is scheduled to vest the day before the 2023 Annual Shareowner Meeting

Read SEC document
May 12, 2022 Filed May 16, 2022 22:50 UTC GrantCommon Stock 2,627 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-029335 · doc4.xml · nonDerivative · entry 1

FRIEL ROBERT F · CIK 0001224110 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,538

F1 · shares: Reflects the award of restricted stock units. The Reporting Person elected to defer the vesting of the RSU Award until Separation from Service.

F2 · balance_after: Amount shown reflects additional shares acquired via a dividend reinvestment plan or DRIP.

Read SEC document
May 12, 2022 Filed May 16, 2022 22:45 UTC GrantCommon Stock 1,812 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-029334 · doc4.xml · nonDerivative · entry 1

LORANGER STEVEN R · CIK 0001226924 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,238

F1 · shares: Reflects the award of restricted stock units. The Reporting Person elected to defer the vesting of the RSU Award until Separation from Service.

F2 · balance_after: Includes RSUs which the reporting person elected to defer the vesting of the award until Separation from Service.

Read SEC document
May 12, 2022 Filed May 16, 2022 22:35 UTC GrantCommon Stock 1,812 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-029330 · doc4.xml · nonDerivative · entry 1

Beliveau-Dunn Jeanne · CIK 0001714894 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,150

F1 · shares: Reflects the issuance of an RSU award which is scheduled to vest the day before the 2023 Annual Shareowner Meeting

F2 · balance_after: Amount shown reflects additional shares acquired via a dividend reinvestment plan or DRIP.

Read SEC document
May 09, 2022 Filed May 10, 2022 17:42 UTC
Pine Matthew FrancisSenior Vice President
Tax withholdingCommon Stock 5,511 $84.98 $468,324.78
Disclosure

SEC source: 0001209191-22-028119 · doc4.xml · nonDerivative · entry 1

Pine Matthew Francis · CIK 0001807057 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,608

F1 · shares: Reflects the withholding of common stock to pay the tax liability incident to the vesting of restricted stock units granted on May 7, 2020 under the Xylem 2011 Omnibus Incentive Plan

Read SEC document
May 09, 2022 Filed May 10, 2022 21:45 UTC
Yarkadas HayatiSenior Vice President
SaleCommon Stock 75 $86.37 $6,477.75
Disclosure

SEC source: 0001209191-22-028122 · doc4.xml · nonDerivative · entry 1

Yarkadas Hayati · CIK 0001657363 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,638

F1 · shares: Reflects the sale of common stock to pay the tax liability incident to the vesting of restricted stock units granted on May 7, 2020 under the Xylem 2011 Omnibus Incentive Plan

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price

Read SEC document
April 18, 2022 Filed Apr 19, 2022 20:00 UTC
Sabol Colin RSenior Vice President
SaleCommon Stock 4,233 $83.05 $351,537.95
Disclosure

SEC source: 0001209191-22-024744 · doc4.xml · nonDerivative · entry 1

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,373

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on March 16, 2022.

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 2,633 Shares were executed at a range of prices from $82.26 to $83.17. 1,600 Shares were executed at a range of prices from $83.39 to $84.21. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

Read SEC document
March 02, 2022 Filed Mar 3, 2022 16:42 UTC
Cerwinka FranzSVP and President, Emerging Ma
SaleCommon Stock 157 $87.84 $13,791.16
Disclosure

SEC source: 0001209191-22-015496 · doc4.xml · nonDerivative · entry 1

Cerwinka Franz · CIK 0001813828 · SVP and President, Emerging Ma

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,738

F1 · shares: Reflects the sale of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price

Read SEC document
March 02, 2022 Filed Mar 3, 2022 22:03 UTC
Yarkadas HayatiSenior Vice President
SaleCommon Stock 43 $87.87 $3,778.41
Disclosure

SEC source: 0001209191-22-015605 · doc4.xml · nonDerivative · entry 1

Yarkadas Hayati · CIK 0001657363 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,255

F1 · shares: Reflects the sale of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price

Read SEC document
March 01, 2022 Filed Mar 2, 2022 16:04 UTC
Cerwinka FranzSVP and President, Emerging Ma
SaleCommon Stock 292 $86.50 $25,256.69
Disclosure

SEC source: 0001209191-22-014671 · doc4.xml · nonDerivative · entry 1

Cerwinka Franz · CIK 0001813828 · SVP and President, Emerging Ma

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,895

F1 · shares: Reflects the sale of common stock to pay the tax liability incident to the vesting of restricted stock units granted on June 12, 2020 under the Xylem 2011 Omnibus Incentive Plan

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price

Read SEC document
March 01, 2022 Filed Mar 2, 2022 21:18 UTC
Yarkadas HayatiSenior Vice President
SaleCommon Stock 71 $86.61 $6,149.64
Disclosure

SEC source: 0001209191-22-014719 · doc4.xml · nonDerivative · entry 1

Yarkadas Hayati · CIK 0001657363 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,298

F1 · shares: Reflects the sale of common stock to pay the tax liability incident to the vesting of restricted stock units granted on May 7, 2020 under the Xylem 2011 Omnibus Incentive Plan

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price

Read SEC document
March 01, 2022 Filed Mar 3, 2022 16:42 UTC
Cerwinka FranzSVP and President, Emerging Ma
GrantStock Option (Right to Buy) · Derivative 8,182 $0.00 Strike: $86.76 $0.00
Disclosure

SEC source: 0001209191-22-015496 · doc4.xml · derivative · entry 3

Cerwinka Franz · CIK 0001813828 · SVP and President, Emerging Ma

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,182

Underlying: Common · 8,182 shares

Expires 2031-03-01

F4 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan, that are scheduled to vest in one third increments on March 1, 2023, March 1, 2024 and March 1, 2025.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 16:42 UTC
Cerwinka FranzSVP and President, Emerging Ma
GrantCommon Stock 1,873 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015496 · doc4.xml · nonDerivative · entry 2

Cerwinka Franz · CIK 0001813828 · SVP and President, Emerging Ma

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,611

F3 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan, that are scheduled to vest in one third increments on March 1, 2023, March 1, 2024 and March 1, 2025.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 16:52 UTC
Pine Matthew FrancisSenior Vice President
GrantStock Option (Right to Buy) · Derivative 15,106 $0.00 Strike: $86.76 $0.00
Disclosure

SEC source: 0001209191-22-015552 · doc4.xml · derivative · entry 3

Pine Matthew Francis · CIK 0001807057 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,106

Underlying: Common · 15,106 shares

Expires 2032-03-01

F3 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan that are scheduled to vest in one third increments on March 1, 2023, March 1, 2024 and March 1, 2025.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 16:52 UTC
Pine Matthew FrancisSenior Vice President
GrantCommon Stock 3,458 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015552 · doc4.xml · nonDerivative · entry 2

Pine Matthew Francis · CIK 0001807057 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,119

F2 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan which are scheduled to vest in one third increments on March 1, 2023, March 1, 2024 and March 1, 2025

Read SEC document
March 01, 2022 Filed Mar 3, 2022 16:52 UTC
Pine Matthew FrancisSenior Vice President
Tax withholdingCommon Stock 217 $86.76 $18,826.92
Disclosure

SEC source: 0001209191-22-015552 · doc4.xml · nonDerivative · entry 1

Pine Matthew Francis · CIK 0001807057 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,661

F1 · shares: Reflects the withholding of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:54 UTC
Rowland Sandra E.Chief Financial Officer
GrantStock Option (Right to Buy) · Derivative 21,400 $0.00 Strike: $86.76 $0.00
Disclosure

SEC source: 0001209191-22-015562 · doc4.xml · derivative · entry 3

Rowland Sandra E. · CIK 0001629360 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,400

Underlying: Common · 21,400 shares

Expires 2032-03-01

F3 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan that are scheduled to vest in one third increments on March 1, 2023, March 1, 2024 and March 1, 2025.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.